Structured or video-game–based core stabilization for children with juvenile idiopathic arthritis
Official title: Comparison of the Effects of Structured Core Stabilization Exercise Training and Exergaming-Based Core Stabilization Training in Children With Juvenile Idiopathic Arthritis
Run by Istanbul University - Cerrahpasa · NCT07234747 · Data updated 2026-11-12
This study will try whether a regular structured core exercise program or a fun exergaming-based core program helps children aged 8–13 with juvenile idiopathic arthritis improve strength, reduce pain, and move better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 12 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Istanbul University - Cerrahpasa Academic / other |
| Locations | 1 site (Istanbul, Buyukcekmece) |
| Status | Recruiting |
| Started | April 10, 2025 |
| Main results expected | November 10, 2025 |
| Study ends | January 10, 2026 |
| Registry record updated | November 18, 2025 |
| Trial ID | NCT07234747 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 8 to 13 with a diagnosis of juvenile idiopathic arthritis for at least six months who can attend in-person exercise sessions and follow the program are the intended participants.
✕Probably not a fit
Children with balance problems from vestibular or neurological conditions, recent surgery within the last six months, or an inability to comply with the exercise program are unlikely to benefit from these interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children with JIA who have had their diagnosis for at least six months will take part in one of two core stabilization programs: a traditional structured exercise program or an exergaming-based program. Interventions are delivered as supervised exercise sessions at the trial site and participants are monitored over the intervention period with measurements taken before and after treatment. Outcomes include pain, mobility, core muscle strength, and program adherence, with participants excluded for vestibular/neurological balance problems or recent surgery that would interfere. The trial compares the two approaches to see if the more engaging exergaming option can match or improve physical and functional outcomes relative to structured exercise.
Why it matters
Potential benefit: If successful, the approach could provide a more engaging way for children with JIA to build core strength, reduce pain, and stay active, improving daily function and quality of life.
How similar studies have gone: General exercise programs have shown benefits for strength and function in children with JIA, and exergaming has shown promise in pediatric rehabilitation, but exergaming specifically for JIA is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 8 and 13 * Having been diagnosed with JIA at least 6 months prior * Willingness to participate in the study Exclusion Criteria: * Having a balance problem due to vestibular or neurological conditions * Having undergone surgery in the last 6 months that may interfere with exercise participation * Inability to comply with the exercise program
Where it's running
-
Istanbul University - Cerrahpasa
Istanbul, Buyukcekmece, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Irem Donmez, Pt. — Istanbul University-Cerrahpasa, Institute of Graduate Studies, Physiotherapy and Rehabilitation Master of Science Program, Istanbul, Türkiye.
- Study coordinator: Irem Donmez, Pt.
- Email: irem.d_8@hotmail.com
- Phone: +905384872702
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting the course of early-onset juvenile idiopathic arthritis using a multidimensional model
Researchers are testing a comprehensive model to predict how early-onset JIA will progress in affected children and how a small control group with iridocyclitis compares.
-
Understanding subtypes of chronic musculoskeletal pain in youth
This observational study tests whether distinct brain and immune profiles can explain chronic musculoskeletal pain in teens and young adults to guide more precise treatments.
-
Open-label extension with filgotinib for juvenile idiopathic arthritis
This long-term open-label extension sees if filgotinib stays safe and continues to control symptoms in children aged 8–17 with polyarticular or systemic juvenile idiopathic arthritis who benefited from earlier treatment.
-
Tofacitinib in Juvenile Idiopathic Arthritis
This study looks at real-world use of tofacitinib to see if it helps control Juvenile Idiopathic Arthritis in kids over about 12 months.
-
Parents' pain catastrophizing in children with juvenile idiopathic arthritis
See if parents' worrying and negative thoughts about their child's pain are linked to treatment adherence and biopsychosocial outcomes in children with juvenile idiopathic arthritis.
-
Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases
This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.